par Firescu, R;Muylle, Kristoff 
;Roelandts, Martine ;de Wind, Alexandre;Moerman, Carine ;Lemort, Marc ;Kentos, Alain ;Meuleman, Nathalie ;Bron, Dominique
Référence Revue médicale de Bruxelles, 32, 2, page (83-92)
Publication Publié, 2011
;Roelandts, Martine ;de Wind, Alexandre;Moerman, Carine ;Lemort, Marc ;Kentos, Alain ;Meuleman, Nathalie ;Bron, Dominique Référence Revue médicale de Bruxelles, 32, 2, page (83-92)
Publication Publié, 2011
Article révisé par les pairs
| Résumé : | Non hodgkin's lymphomas are a group of haematological malignancies in which spectacular progress has been made over the last ten years thanks to immunotherapy. Furthermore, the new WHO classification, based upon tumour immunology, the degree of tumour differentiation and cytogenetic abnormalities, has finally improved identification of each lymphoma and has enabled comparison of homogeneous populations between different clinical studies. The increase in the incidence of non hodgkin's lymphoma is related to the aging of the population and to other factors that are yet to be elucidated--a real challenge for the future. We have tried to offer an overview of the latest therapeutic advances, with a focus on (radio-) immunotherapy and haemopoietic stem cell transplantation. |
